Infinium Pharmachem Limited was originally incorporated as "Infinium Pharmachem Private Limited" on November 21, 2003 issued by the Registrar of Companies, Gujarat. Later on, Company converted its status into Public Company and the name of Company was changed to "Infinium Pharmachem Limited" vide fresh Certificate of Incorporation dated August 12, 2022. Company is engaged in manufacturing and selling of Iodian based Pharmaceutical Intermediates . The Company has its manufacturing plant at Dist. Anand, Gujarat, since inception.
The Company`s manufacturing capabilities and technical expertise have catered industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics, etc. Apart from these, it provides a range of Iodine derivatives in the market, with more than 200 intermediates and over 7 APIs.
Later, in 2019, the Company formed a Joint Venture (JV) with Shanghai Witofly Chemical Co. Ltd., in the name of Shanghai Tajilin Industrial Co. Ltd., in the People`s Republic of China. It also formed a Subsidiary Company in the name of Infinium Green Energy Private Limited on June 06, 2022.
The Company came up with a public issue of 18,75,000 Equity Shares of face value of Rs 10 each by raising funds aggregating to Rs 25.25 Crore in April, 2023.
In FY2025, Company completed the expansion cum modernization of iodine derivatives manufacturing facility in Anand District of Gujarat. The installed production capacity increased to 1,800 MT per annum during the year. The Company further launched a new product line `IOHEXOL (API)` in FY25.
Infinium Pharmachem share price as on 02 Mar 2026 is Rs. 208.95. Over the past 6 months, the Infinium Pharmachem share price has decreased by 21.74% and in the last one year, it has decreased by 11.84%. The 52-week low for Infinium Pharmachem share price was Rs. 204 and 52-week high was Rs. 337.
Infinium Pharmachem Limited was originally incorporated as "Infinium Pharmachem Private Limited" on November 21, 2003 issued by the Registrar of Companies, Gujarat. Later on, Company converted its status into Public Company and the name of Company was changed to "Infinium Pharmachem Limited" vide fresh Certificate of Incorporation dated August 12, 2022. Company is engaged in manufacturing and selling of Iodian based Pharmaceutical Intermediates . The Company has its manufacturing plant at Dist. Anand, Gujarat, since inception.
The Company`s manufacturing capabilities and technical expertise have catered industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics, etc. Apart from these, it provides a range of Iodine derivatives in the market, with more than 200 intermediates and over 7 APIs.
Later, in 2019, the Company formed a Joint Venture (JV) with Shanghai Witofly Chemical Co. Ltd., in the name of Shanghai Tajilin Industrial Co. Ltd., in the People`s Republic of China. It also formed a Subsidiary Company in the name of Infinium Green Energy Private Limited on June 06, 2022.
The Company came up with a public issue of 18,75,000 Equity Shares of face value of Rs 10 each by raising funds aggregating to Rs 25.25 Crore in April, 2023.
In FY2025, Company completed the expansion cum modernization of iodine derivatives manufacturing facility in Anand District of Gujarat. The installed production capacity increased to 1,800 MT per annum during the year. The Company further launched a new product line `IOHEXOL (API)` in FY25.
Infinium Pharmachem share price as on 02 Mar 2026 is Rs. 208.95. Over the past 6 months, the Infinium Pharmachem share price has decreased by 21.74% and in the last one year, it has decreased by 11.84%. The 52-week low for Infinium Pharmachem share price was Rs. 204 and 52-week high was Rs. 337.
